← Back to All Filings

Institutional Holder Sells $457k in Firefly Neuroscience (AIFF)

Medium SignificanceOctober 14, 2025 at 7:36:10 PM EDT

FIREFLY NEUROSCIENCE, INC.

$AIFF4CIK: 0000803578

Subscribe to track AIFF

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Institutional Holder Sells $457k in Firefly Neuroscience (AIFF)

Company: FIREFLY NEUROSCIENCE, INC. (AIFF) Form: 4 | Filed: 2025-10-14 Significance: Medium

Insider: Windsor Private Capital LP Title: null | Relationship: 10% Owner

Transaction (Aggregated over 4 days): • Type: Sell • Shares: 166,572 • Avg. Price: $2.74 • Value: $456,678 • Owned After: 1,470,201

Key Insight: A 10% owner group sold a notable amount of stock over four consecutive trading days. While not a full exit, this represents a significant reduction in their position.

Market Context: The sales were conducted under Rule 144. The selling entity, Windsor Private Capital, is part of a larger group of reporting persons.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: FIREFLY NEUROSCIENCE, INC. (AIFF)

Executive Summary

  • Trading Significance: Medium
  • Key Takeaway: A group of 10% owners, led by Windsor Private Capital LP, executed a series of sales totaling approximately $457,000 over four trading days, reducing their collective stake by about 10%.
  • Market Impact: This consistent selling pressure from a major institutional holder could be perceived as a bearish signal by the market, potentially leading to negative short-term price pressure. The sales were conducted under Rule 144.

Company Information

FieldValue
CompanyFIREFLY NEUROSCIENCE, INC.
Ticker SymbolAIFF
CIK0000803578
IndustrySERVICES-PREPACKAGED SOFTWARE [7372]

Insider Information

FieldValue
NameWindsor Private Capital LP
CIK0002034160
Title/Positionnull
Relationship10% Owner

Transaction Details

This Form 4 reports four separate sale transactions. The details below are aggregated.

FieldValue
Form Type4
Transaction Date2025-10-09 to 2025-10-14
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved166,572
Price Per Share$2.7416 (Weighted Average)
Total Value$456,677.55
Shares Owned After1,470,201
Ownership TypeIndirect

Detailed Transaction Breakdown:

  • Oct 9: Sold 30,126 shares @ $2.9441
  • Oct 10: Sold 74,810 shares @ $2.6994
  • Oct 13: Sold 32,136 shares @ $2.6525
  • Oct 14: Sold 29,500 shares @ $2.7390

Market Impact Analysis

Stock Impact Prediction

  • Direction: Negative/Neutral
  • Reasoning: A sale of this size from a major institutional holder can be interpreted negatively, suggesting profit-taking or a reduced conviction in the company's short-to-medium term prospects. However, since the group retains a very large position (over 1.4M shares), it is not a complete exit, which may temper the negative impact.

Volume & Sentiment

  • Expected Volume Impact: The trades likely contributed to increased trading volume on the transaction dates. The public disclosure may cause a short-term spike in volume as the market digests the news.
  • Sentiment Indicator: Bearish. Sales from 10% owners, especially when spread over several days, are generally viewed as a bearish signal, indicating a desire to liquidate a portion of the position.

Investment Insights

Positive Market Indicators

  • The insider group still maintains a substantial holding of over 1.47 million shares, indicating continued significant investment in the company.

Risk Factors

  • The series of sales over four consecutive trading days indicates a deliberate and persistent effort to reduce exposure.
  • As a 10% owner, the selling group has significant insight into the company, making their sales more noteworthy than those of a smaller retail investor.

Key Takeaways

  1. Significant Liquidation: The sale of 166,572 shares represents a material reduction (approx. 10%) of the insider group's holdings.
  2. Group Action: The filing was made jointly by a group of entities and individuals associated with Windsor Private Capital, indicating a collective decision to sell.
  3. Rule 144 Sale: The transactions were conducted under Rule 144, which governs the sale of restricted securities. This is a standard procedure for insiders and large shareholders.

Contextual Analysis

Timing Significance

The sales occurred over a four-day period, suggesting a planned liquidation rather than a single reactive trade. The varying prices indicate the sales were executed at prevailing market rates on each day.

Transaction Context

Footnote 3 clarifies the complex ownership structure. The shares are held directly by Windsor Private Capital LP. Several individuals (Rocco Marcello, John Cundari, Jordan Kupinsky) and related entities are considered part of the reporting group due to their control and/or financial interest in Windsor Private Capital. They disclaim beneficial ownership beyond their pecuniary interest.

Company Context

Without specific recent news on Firefly Neuroscience, Inc., the analysis is limited to the filing itself. Investors should correlate this insider activity with recent company announcements, earnings reports, and overall sector performance.

Risk Assessment

Risk Level: Medium

Risk Factors

  • Profit-Taking: The sales could simply be a strategic move to realize profits or rebalance a portfolio.
  • Loss of Confidence: The sales could signal a diminished outlook on the company's future performance by a well-informed institutional owner.
  • Market Overhang: The knowledge that a large holder is actively selling could create a 'market overhang,' where investors anticipate further sales, suppressing the stock price.

Market Considerations

  • The market's reaction will depend on the company's recent performance and news flow.
  • The overall market sentiment for the prepackaged software industry will influence how this specific insider sale is perceived.
  • The remaining large stake could be a source of future selling pressure.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-15 | Data source: SEC EDGAR

Topics:#SECFiling#InsiderTrading#AIFF#FireflyNeuroscience#Form4#InsiderSell#StockMarket#Investing#MarketAnalysis#Finance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.